Impact and Challenges With Vitamin D to Treat Secondary ...
4.1K
Description

Impact and Challenges With Vitamin D to Treat Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease 



Ergocalciferol (D2)

Cholecalciferol (D3)

 - Effective in repleting 25-D and 1,25-D in patients with early-stage CKD and adequate kidney function 

ER Calcifediol 

 - Effective in repleting 25-D and 1,25-D in patients with CKD 3 and 4 

 - Effectively suppresses SHPT 

Calcitriol 

 - Biologically active VDR agonist 

 - Effectively suppresses SHPT 

 - Reduces abnormal high bone turnover 

Doxercalciferol 

 - Suppresses SHPT similar to or better than calcitriol 

 - Noted reduction in serum bone-specific alkaline phosphatase and osteocalcin 

Alphacalcidol 

 - Suppresses SHPT similar to or better than calcitriol 

Paricalcitol 

 - Biologically active VDR agonist 

 - Effectively suppresses SHPT 

 - Noted reduction in serum bone-specific alkaline phosphatase and osteocalcin 



Dr. Edgar V. Lerma @edgarvlermamd - Nephrology Secrets https://amzn.to/34t5DgJ



#VitaminD #Secondary #Hyperparathyroidism #CKD #Nephrology #Management #Pharmacology #Cholecalciferol #Calcitriol
Contributed by

Dr. Gerald Diaz
@GeraldMD
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Medical jobs
view all

0 Comments

Related content